¼ÓÈëVIP ÉÏ´«¿¼²©×ÊÁÏ ÄúµÄÁ÷Á¿ Ôö¼ÓÁ÷Á¿ ¿¼²©±¨°à ÿÈÕÇ©µ½
   
Ö÷Ìâ : Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)
¼¶±ð: ×Ü°æÖ÷
ÏÔʾÓû§ÐÅÏ¢ 
Â¥Ö÷  ·¢±íÓÚ: 2007-01-25   

Ò»¾Å¾Å¾ÅÄ격ʿÉúÈëѧ¿¼ÊÔÊÔÌâ(רҵ»ù´¡: ÃâÒßѧ)

Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ I;+>@Cn(g<  
u$ff %`E  
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© }$@E pM  
_l=X?/  
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© OpLUmn  
y4Lh:;  
1.Co-stimulators (or co-stimulating molecules) DT3koci(  
y)mtSA8  
2.NK-kB 1-} M5]Y  
BjV;/<bt  
3.Immunoglobulin superfamily s7s@!~  
T0"q,lrdxV  
4.antigen-presenting cell (APC) |6 E !wW  
mO&zE;/[  
5.death domain ]:.9:RmEV  
X][=(l!;w7  
6.CCR and CXCR ][B>`gC-  
1ZO/R%[  
7.Lectin (or mitogen) kerBy\^  
2q ~y\fe  
8.Clusters of differentiation, CD) Eg4_kp0Lq  
wVkRrFJ  
9.B7 family LTcZdQd$  
TV~S#yg+H  
10.Cytotoxic T lymphocyte, CTL) 4ZtsLMwLD  
WT jy"p*  
11.IL-15 and IL-15 receptor (IL-15R) 4rUOk"li  
,D2nUk  
12.MHC restriction G<Y}QhFU  
9{8xMM-  
13.Affinity-chromatography +^ `n- m  
N1Dr'aw*  
14.Cyctosprin A, CsA DVjwY_nG7  
R <;;Ph  
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) !7Nz_d~n  
 \nU_UH  
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© lH/7m;M  
,M=s3D 8C  
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 $Z<x r  
,$Xhw r  
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØϵ¡£ s PvjJr"s  
dz1kQzOU*  
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹Ô­µÄÌص㡣 ^J)0i_RS  
T l8`3`e  
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© ]nq/y AF%  
qm< mw"]  
ÃâÒßѧרҵ£º 2b&Fu\2Dmv  
V#X<Yt  
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ WJy\{YAG  
OJD!Ar8Q  
Ïû»¯ÄÚ¿Æ£º e?+&2zMq  
Y6m:d&p=}  
2.Ö×Áö¿¹Ô­·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ P4fnBH4OQ  
eu'S~c-l  
ѪҺ²¡Ñ§×¨Òµ£º w9675D+  
w%-S5#  
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎΪÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔ­Òò£¨Ìõ¼þ£©ÊÇʲô£¿
ÆÀ¼ÛÒ»ÏÂÄãä¯ÀÀ´ËÌû×ӵĸÐÊÜ

¾«²Ê

¸Ð¶¯

¸ãЦ

¿ªÐÄ

·ßÅ­

ÎÞÁÄ

¹àË®

  
ÃèÊö
¿ìËٻظ´

ÑéÖ¤ÎÊÌâ:
Ãâ·Ñ¿¼²©ÂÛ̳ÍøÖ·ÊÇʲô? ÕýÈ·´ð°¸:freekaobo.com
°´"Ctrl+Enter"Ö±½ÓÌá½»